Similar Stories to Amgen Shares Rise On Positive Bone-drug Study - Businessweek on Bing News

Health JackalAmgen shares rise on positive bone-drug studyBusinessWeekShares of Amgen Inc. jumped in premarket trading Wednesday after the company said its experimental osteoporosis drug denosumab met a key goal of preventing bone injuries in breast-cancer patients during a late-stage study. Its shares gained $7.22, ...Amgen Rises After Denosumab Bests Zometa in StudyBloombergAmgen Climbs Premarket On Bone Drug Trial >AMGNWall Street JournalAmgen shares jump after bone drug does well in testBizjournals.comHealth Jackal -MSN Money -Market Intelligence Centerall 72 news articles »

BING NEWS:
  • Biosimilar Updates: Celltrion, Costco Partnership; Amgen Sues Samsung Bioepis; Denosumab Results
    Amgen sues Samsung biotech unit over bone drug copies. Reuters ... GlycoNex successfully completes phase 1 study of denosumab biosimilar, SPD8. Press release. GlycoNex; August 19, 2024.
    08/24/2024 - 1:00 pm | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News